Targeting Chemokines and Chemokine GPCRs to Enhance Strong Opioid Efficacy in Neuropathic Pain

Targeting Chemokines and Chemokine GPCRs to Enhance Strong Opioid Efficacy in Neuropathic Pain

Neuropathic pain (NP) originates from an injury or disease of the somatosensory nervous system. This heterogeneous origin and the possible association with other pathologies make the management of NP a real challenge. To date, there are no satisfactory treatments for this type of chronic pain. Even...

Full description

Bibliographic Details
Main Authors: Martina Vincenzi, Michele Stanislaw Milella, Ginevra D’Ottavio, Daniele Caprioli, Ingrid Reverte, Daniela Maftei
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Life
Subjects:
neuropathic pain
strong opioids
chemokines
chemokine receptors
GPCRs
chemokine receptor antagonist
Online Access:https://www.mdpi.com/2075-1729/12/3/398

Internet

https://www.mdpi.com/2075-1729/12/3/398

Similar Items